Alcohol Detox in Palm Beach, FL

Alcohol withdrawal is one of the most medically serious drug withdrawal syndromes that exists. Unlike opioid withdrawal — which is intensely uncomfortable but rarely life-threatening — alcohol withdrawal can kill. Seizures, delirium tremens, and cardiovascular complications are real risks for patients who stop drinking after prolonged heavy use without medical supervision. Dr. Mark G. Agresti, M.D., a board-certified psychiatrist with more than 30 years of clinical experience, provides medically supervised outpatient alcohol detox in Palm Beach — a structured, physician-directed program that safely guides patients through withdrawal and into the beginning of lasting recovery.

This is not a detox managed by a call center or monitored monthly. Dr. Agresti’s concierge model means direct cell phone access, text messaging for symptom questions, one flat fee for the detox episode, and no annual membership required. Telehealth is available for patients throughout Florida.

Why Alcohol Detox Needs Medical Supervision

Alcohol acts primarily as a GABA-A receptor agonist and NMDA glutamate receptor antagonist. Put simply: alcohol is a CNS depressant, and the brain adapts to chronic alcohol exposure by upregulating excitatory neurotransmission and downregulating inhibitory neurotransmission. This neurological adaptation is what creates physical dependence. When alcohol is abruptly removed, the brain’s excitatory-inhibitory balance is suddenly disrupted — the excitatory systems are up-regulated, the inhibitory ones are down, and there is nothing dampening the resulting neurological storm.

The consequences of unchecked alcohol withdrawal can be severe:

• Generalized tonic-clonic seizures — occurring most commonly in the first 24 to 48 hours after the last drink. A first seizure in someone unknown to have a seizure disorder is a medical emergency.
• Delirium tremens (DTs) — occurring in a smaller percentage of patients, typically beginning 48 to 96 hours after the last drink. DTs involve confusion, agitation, fever, profuse sweating, rapid heart rate, and hallucinations. Without treatment, delirium tremens carries a mortality rate of 5 to 15 percent.
• Autonomic instability — severely elevated blood pressure, rapid heart rate, and the potential for cardiac arrhythmias in predisposed patients.

If you drink heavily every day, you should not stop drinking without a medical plan in place. Call Dr. Agresti before stopping — not after. A brief consultation to assess your withdrawal risk and initiate a safe detox protocol is far preferable to an emergency room visit.

The Detox Process — Librium Tapering Protocol

The gold standard medical treatment for alcohol withdrawal is benzodiazepine therapy. Benzodiazepines, like alcohol, enhance GABA activity — they fill the neurological gap left by alcohol’s removal, preventing the unchecked excitatory surge that causes seizures and delirium. Dr. Agresti uses chlordiazepoxide (Librium) as the primary detox medication, which is the most extensively studied and widely used agent for this purpose.

Chlordiazepoxide has several properties that make it particularly well-suited for alcohol detox: it has a long half-life (with active metabolites providing coverage for 24 to 48 hours per dose), it has a smooth pharmacological profile that provides consistent coverage without the peaks and troughs of short-acting benzodiazepines, and it has been used safely for alcohol withdrawal management for decades with an extensive evidence base.

Dr. Agresti uses the CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) — a validated scoring tool that quantifies withdrawal severity based on symptoms — to guide dosing decisions. CIWA scoring assesses nausea, tremor, sweating, anxiety, agitation, perceptual disturbances, and other withdrawal symptoms, producing a numerical score that corresponds to withdrawal severity. This allows Dr. Agresti to calibrate chlordiazepoxide doses to each patient’s actual symptoms rather than applying a rigid protocol that may be too aggressive for one patient and inadequate for another.

In practice, the Librium taper works as follows:

• Induction (Day 0–1): Chlordiazepoxide is initiated at a dose appropriate to the patient’s withdrawal severity, drinking history, and physical characteristics. Initial doses may be higher for patients with severe dependence or prior seizure history.
• Active taper (Days 2–7): Chlordiazepoxide doses are tapered progressively downward, guided by CIWA scoring and symptom reports. Patients communicate directly with Dr. Agresti via text and phone, reporting symptoms and receiving dosing guidance in real time.
• Resolution (Days 7–10): By the end of the first week, most patients have completed the Librium taper and are through the acute withdrawal phase. Chlordiazepoxide is discontinued, and the focus shifts to ongoing recovery support.

What to Expect During Alcohol Withdrawal

Understanding the withdrawal timeline helps patients and their support systems know what to expect and when to be most vigilant:

• Hours 6–24 after last drink: The earliest withdrawal symptoms emerge — anxiety, tremor, sweating, nausea, headache, and elevated heart rate. This is the window when chlordiazepoxide should be initiated.
• Hours 24–48: Withdrawal intensity peaks. This is when seizure risk is highest. With proper Librium coverage, seizures should not occur; without it, the risk is significant in heavy drinkers.
• Hours 48–96: For most patients on appropriate medical therapy, symptoms are subsiding by this point. However, this is the window for delirium tremens in the small percentage of patients who develop it. Any confusion, fever, or hallucinations warrant immediate medical attention.
• Days 4–7: Acute physical symptoms continue to resolve. Sleep remains disturbed, anxiety persists, and mood is often low. Most patients are through the medical danger zone but still need close monitoring.
• Weeks 2–4: Protracted withdrawal syndrome — persistent anxiety, sleep disruption, mild cognitive impairment, and mood instability — can continue for weeks after the acute detox. This period requires ongoing psychiatric support to prevent relapse driven by these symptoms.

Dr. Agresti monitors patients through every phase of this timeline via direct phone and text communication, providing dosing guidance, reassurance, and rapid response if symptoms escalate beyond expected parameters.

Ongoing Recovery — Tailored Medication Options

Alcohol detox addresses the acute physical withdrawal. But recovery from alcohol use disorder requires sustained support for the neurological changes and psychological patterns that developed over years of heavy drinking. Dr. Agresti offers all established FDA-approved medications for alcohol use disorder maintenance, chosen based on each patient’s individual profile, medical history, and preferences. There is no single “standard” medication — the right choice depends on the individual.

Naltrexone (Oral Daily)

Naltrexone is an opioid receptor antagonist that works in alcohol use disorder by blocking the opioid-mediated reward that alcohol produces. When opioid receptors are blocked, alcohol loses much of its reinforcing effect — drinking becomes less pleasurable, and the cravings driven by conditioned reward are reduced. Daily oral naltrexone (50 mg) is one of the most well-studied medications for alcohol use disorder, with a large body of evidence supporting its ability to reduce heavy drinking days and increase abstinence rates. It is best suited for patients who are motivated to take a daily medication and who want to reduce cravings from the first days of recovery.

Vivitrol (Monthly Naltrexone Injection)

Vivitrol is an extended-release formulation of naltrexone delivered as a once-monthly intramuscular injection. It provides the same opioid receptor antagonism as oral naltrexone, but eliminates the compliance challenges of daily dosing — once the injection is given, the medication is active for the full month regardless of whether the patient remembers to take a pill. For patients with a history of medication non-adherence, who travel frequently, or who simply prefer the simplicity of a monthly appointment, Vivitrol offers significant practical advantages. Vivitrol is used for ongoing relapse prevention after detox is complete — it is not part of the acute detox protocol.

Disulfiram (Antabuse)

Disulfiram works on a completely different principle from naltrexone. It inhibits aldehyde dehydrogenase, an enzyme required for normal alcohol metabolism. When a patient taking disulfiram drinks alcohol, acetaldehyde — a toxic intermediate metabolite — accumulates in the blood, producing an intensely unpleasant reaction: flushing, nausea, vomiting, palpitations, and headache. This aversive reaction serves as a powerful deterrent to drinking. Disulfiram is most effective for patients who have a strong motivation to avoid alcohol and who benefit from an external behavioral barrier. Because the reaction can be severe in patients with cardiovascular disease, Dr. Agresti conducts a careful medical assessment before prescribing disulfiram.

Acamprosate (Campral)

Acamprosate is believed to work by modulating the NMDA glutamate system — partially restoring the neurochemical balance disrupted by chronic alcohol use. It does not produce an aversive reaction to alcohol like disulfiram, nor does it block alcohol’s rewarding effects like naltrexone. Instead, it appears to reduce the protracted withdrawal symptoms — anxiety, dysphoria, sleep disruption — that drive relapse in the weeks and months after acute detox. Acamprosate may be particularly useful for patients who experience significant protracted withdrawal syndrome, or who have medical contraindications to naltrexone (such as current opioid use or significant liver disease). It is taken three times daily and requires normal kidney function.

Concurrent Psychiatric Treatment

Alcohol use disorder has one of the highest co-occurrence rates with other psychiatric conditions of any substance use disorder. Major depression, generalized anxiety disorder, bipolar disorder, PTSD, and social anxiety disorder all co-occur with alcohol use disorder at rates that far exceed chance. The relationship is bidirectional: psychiatric illness increases the risk of developing alcohol use disorder, and chronic heavy alcohol use causes or worsens psychiatric symptoms.

Identifying and treating co-occurring psychiatric conditions is not an optional add-on to alcohol recovery — it is often the decisive factor in whether recovery is sustained. A patient who stops drinking but remains untreated for major depression is at high risk for relapse driven by the depressive symptoms. A patient with undiagnosed bipolar disorder who achieves sobriety may find that emerging hypomanic or depressive episodes drive drinking relapse without adequate mood stabilization.

Dr. Agresti provides comprehensive psychiatric evaluation and treatment for all co-occurring conditions — depression, anxiety, bipolar disorder, and others — as integral components of alcohol use disorder treatment, not separate services. This is the psychiatric model of addiction care, and it produces better long-term outcomes than addiction treatment that ignores co-occurring mental illness.

Learn more about Dr. Agresti’s broader Medication-Assisted Treatment program and his concierge psychiatry practice. Telehealth is available for patients throughout Florida.

Concierge Alcohol Detox — One Flat Fee, Full Medical Support

Dr. Agresti’s concierge alcohol detox program is designed around the reality that safe alcohol withdrawal requires close, continuous physician contact — not a clinic visit every three days. Here is what the concierge model provides:

• One flat fee for the detox episode — covers the initial assessment, the entire Librium taper, and all physician contact during the acute withdrawal period. No surprise billing. No annual membership.
• Direct cell phone access to Dr. Agresti — you have Dr. Agresti’s personal cell number. When you are on day two of withdrawal and your symptoms are concerning you, you call your doctor — not a nurse line.
• Text messaging for symptom questions during the taper — “I’m sweating more than yesterday, heart is racing a bit — is this within expected range?” These are exactly the questions that deserve real-time physician attention, and the concierge model makes this possible.
• Outpatient, at-home detox — for appropriately selected patients, outpatient alcohol detox with proper medical oversight is as safe as inpatient care, and dramatically more comfortable. There is no need to check into a facility, be away from family, or disrupt your life beyond what the detox itself requires.
• No annual membership required — pay for the care you actually receive.
• Telehealth available throughout Florida — ongoing follow-up appointments for recovery medication management can be conducted via telehealth, making specialist-level care accessible statewide.

Dr. Agresti’s office is at 44 Cocoanut Row, Suite M-202, Palm Beach, FL 33480. He evaluates every patient carefully before initiating outpatient alcohol detox — patients with severe dependence, prior seizure history, or significant medical comorbidities may be referred to a monitored setting for the acute withdrawal phase. Patient safety is the first consideration in every treatment decision.

Start Your Alcohol Recovery Today

If you are dependent on alcohol and want to stop safely, please do not wait — and please do not try to stop on your own. Dr. Agresti provides the medical supervision, direct physician access, and individualized care that safe alcohol withdrawal requires.

Recovery from alcohol use disorder is absolutely possible. Dr. Agresti has helped many patients in Palm Beach and throughout South Florida achieve lasting sobriety through the combination of medically supervised detox, individualized maintenance medication, and comprehensive psychiatric treatment. The concierge model ensures that you are never navigating this alone.

Schedule your consultation: Call or text 561-760-4107.
After-hours emergency line: 561-386-7743.
Office: 44 Cocoanut Row, Suite M-202, Palm Beach, FL 33480.
Telehealth appointments available for Florida residents statewide.